A medical device CRO differs from a pharma CRO in the regulations it works under, the studies it runs, and the kind of support it gives.
A pharma CRO operates under ICH GCP and runs pre-market drug trials for clients with mature clinical teams. A medical device or IVD CRO works under ISO 14155 or ISO 20916, often runs post-market and performance studies, and acts as a hands-on partner for manufacturers building clinical evidence for the first time. For device and IVD developers, that distinction determines whether a partner is a good fit for the work.
What does a medical device CRO do differently from a pharma CRO?
A medical device CRO runs clinical investigations and performance studies for device and IVD manufacturers under ISO 14155 and ISO 20916, rather than the ICH GCP drug-trial framework a pharma CRO uses. It typically supports smaller manufacturers with strategic and operational support, from lean study design through to documentation for CE marking, rather than focusing solely on large multi-country trial execution.
Both kinds of CRO share the same foundations of patient safety, clinical integrity, and reliable data, but the compliance route and the path to market approval look very different. The sections below break down where those differences actually bite: terminology, standards, regulatory frameworks, study design, and the support manufacturers need.
Why does the study document have a different name in each field?
The core study document is named differently across sectors because each operates under its own regulatory regime. Pharma calls it the Clinical Study Protocol; medical devices call it the Clinical Investigation Plan; in vitro diagnostics call it the Clinical Performance Study Plan. All three describe a study’s design, conduct, and objectives. The different names signal different rules, not different purposes.
That terminology gap is the easiest difference to spot and a useful early signal. A partner who reaches for the pharma term in a device context may not be fluent in the framework your submission will be judged against.
Which standards and guidelines govern each type of study?
Each study type follows its own standard. The three that matter:
- Pharma clinical trials, governed primarily by ICH E6 (R3) Good Clinical Practice.
- Medical device studies, conducted to ISO 14155:2020, the standard for clinical investigation of medical devices in human subjects.
- IVD performance studies, following ISO 20916:2019, covering clinical performance studies using specimens from human subjects.
The standard a study is built on shapes everything downstream, from documentation and monitoring expectations to how evidence is presented to a notified body. Matching CRO expertise to the right standard is a practical necessity, not a formality.
Which EU regulations apply to pharma, device, and IVD studies?
In the European Union, three separate regulations reinforce these distinctions, each with its own submission and compliance route:
- Clinical Trial Regulation, Regulation (EU) No 536/2014, for medicinal products.
- Medical Device Regulation, MDR (EU) 2017/745, for medical devices.
- In Vitro Diagnostic Regulation, IVDR (EU) 2017/746, for in vitro diagnostics.
Choosing the right pathway up front keeps a study moving. A submission built to the wrong framework invites avoidable delays and regulatory setbacks, and this is the area where specialized device and IVD knowledge pays for itself.
How do the study purposes and designs differ across the three fields?
Study purpose differs sharply by sector. Pharma studies are usually pre-market and innovative, designed to win product approval. Medical device studies in the EU lean toward post-market surveillance and observational investigations, driven by MDR requirements. IVD performance studies are different again. They may use existing samples such as blood or tissue, sometimes with no direct subject contact.
These differences ripple through everything from recruitment to data collection and ethical review. A CRO that understands them designs the study to fit the product category and regulatory expectation, rather than forcing a drug-trial template onto a device or diagnostic.
What kind of support do device and IVD manufacturers need from a CRO?
Device and IVD manufacturers generally need more strategic and hands-on support than pharma clients. Many are smaller companies bringing a breakthrough technology to market for the first time, without in-house clinical or regulatory infrastructure. They need a CRO that provides direction and practical execution, not just operational capacity for a trial they already know how to run.
Pharma clients
Pharma CROs typically work with companies that already hold deep clinical-trial expertise, dedicated regulatory teams, and defined development strategies. With that infrastructure in place, the CRO can concentrate on operational excellence: delivering large-scale, multi-country trials with precision and reliability.
Medical device manufacturers
Device manufacturers are often smaller or mid-sized and may be navigating the clinical and regulatory landscape for the first time. They look for a CRO that offers both strategic direction and practical, hands-on support, from designing lean but compliant investigations to preparing documentation for CE marking under the MDR. A device-focused CRO acts as an extension of the client’s team, turning technical innovation into clinical evidence.
IVD manufacturers
IVD manufacturers face their own challenges: analytical performance, sample handling, and compliance with ISO 20916. Their studies often require close coordination among laboratories, hospitals, and data management experts. An experienced IVD-focused CRO bridges those elements so each study delivers credible clinical performance data aligned with IVDR requirements.
Because device and IVD companies usually work within tighter budgets and timelines than large pharma, their studies reward creativity and operational efficiency. CROs specialized in these fields are built to:
- operate with flexibility and cost efficiency;
- provide end-to-end guidance from protocol design to submission support;
- align each study with MDR or IVDR clinical and performance-evidence requirements;
- act as long-term partners, helping manufacturers reach regulatory milestones and market readiness.
Taken together, this mix of flexibility, expertise, and partnership enables device- and IVD-focused CROs to bring innovations to patients safely, effectively, and on schedule.
Learn more about working with a medical device CRO
If you’re weighing up a partner for a device or IVD study, the next step is understanding what a specialized medical device CRO actually delivers across clinical investigations, PMCF, IVD performance studies, and submission support. That page sets out how Qserve supports manufacturers end-to-end.
Prefer to talk it through? You can also book a free 30-minute consultation with Celien to discuss your specific study.